<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Scientific</title>
<description>International Business News - Scientific</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Boston Scientific shares fall to 52-week low</title>
  <description>Shares of medical device maker Boston Scientific Corp. hit a new 52-week low Friday as markets continued to tumble, extending a week of huge losses in equities.</description>
    <link>http://www.ibtimes.com/articles/20081010/boston-scientific-shares-fall-to-52-week-low.htm</link> 
  <pubDate>Fri, 10 Oct 2008 20:09:35 EDT</pubDate>
  </item>


  <item>
  <title>FDA approves long-delayed Boston Scientific stent</title>
  <description>Boston Scientific Corp. said Friday the Food and Drug Administration approved its long-delayed follow-up to the drug-coated stent Taxus. The company said it will launch Taxus Liberte in the U.S. early next month. The stent has been available in Europe since 2005, but was delayed in the U.S. by a sweeping warning letter issued by the FDA in 2006 over corporate quality issues. Such warning letters restrict the approval of new products.</description>
    <link>http://www.ibtimes.com/articles/20081010/fda-approves-long-delayed-boston-scientific-stent.htm</link> 
  <pubDate>Fri, 10 Oct 2008 14:09:34 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific shares fall to 52-week low</title>
  <description>Shares of Boston Scientific dropped to a 52-week low Thursday a day after the involuntary sell-off of 13 million shares by the medical device firm's co-founders.</description>
    <link>http://www.ibtimes.com/articles/20081009/boston-scientific-shares-fall-to-52-week-low.htm</link> 
  <pubDate>Thu, 09 Oct 2008 12:53:51 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific: sell-off was involuntary</title>
  <description>Boston Scientific Corp. said Thursday a major sell-off of its stock was due to involuntary selling by its co-founders, and did not reflect on the company's performance.</description>
    <link>http://www.ibtimes.com/articles/20081009/boston-scientific-sell-off-was-involuntary.htm</link> 
  <pubDate>Thu, 09 Oct 2008 13:52:10 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific outlines 3Q charges, gains</title>
  <description>Boston Scientific said Wednesday it will report up to $514 million in charges for the third quarter, due to a negative ruling in a patent dispute and other impairment charges.</description>
    <link>http://www.ibtimes.com/articles/20081008/boston-scientific-outlines-3q-charges-gains.htm</link> 
  <pubDate>Wed, 08 Oct 2008 16:36:04 EDT</pubDate>
  </item>


  <item>
  <title>Gerber Scientific won't raise bid for Virtek</title>
  <description>Gerber Scientific Inc. said Wednesday it stands by its offer to buy industrial laser maker Virtek Vision International Inc., and will not increase its bid.</description>
    <link>http://www.ibtimes.com/articles/20081008/gerber-scientific-wont-raise-bid-for-virtek.htm</link> 
  <pubDate>Wed, 08 Oct 2008 15:12:58 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific gets FDA approval for new stent</title>
  <description>Boston Scientific Corp. said Thursday the Food and Drug Administration approved the medical device maker's new Taxus drug-coated stent. The approval comes as Boston Scientific and its stent competitors try to recover from a yearlong downturn in sales for the devices which are used to prop open clogged arteries. The drug-coatings are used to prevent the growth of scar tissue.</description>
    <link>http://www.ibtimes.com/articles/20080925/boston-scientific-gets-fda-approval-for-new-stent.htm</link> 
  <pubDate>Thu, 25 Sep 2008 08:31:30 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific won't get new stent patent trial</title>
  <description>Medical device maker Boston Scientific Corp. said an appeals court denied its request for a new trial of a patent case brought by Johnson &amp; Johnson. Late Monday, Boston Scientific said the U.S. District Court in Delaware granted Johnson &amp; Johnson's motion for entry of final judgment and refused to allow a new trial. In 2000, Boston Scientific said a jury found the company had violated a patent with its NIR stent, and awarded Johnson &amp; Johnson, maker of the Palmaz balloon stent, $324 million.</description>
    <link>http://www.ibtimes.com/articles/20080916/boston-scientific-wont-get-new-stent-patent-trial.htm</link> 
  <pubDate>Tue, 16 Sep 2008 14:40:26 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific spent $400K lobbying gov't in 2Q</title>
  <description>Medical device maker Boston Scientific Corp. spent $400,000 lobbying the federal government in the second quarter, according to a disclosure form. Boston Scientific lobbied for greater access to foreign markets, including Japan, Korea, China, Brazil, and countries in the European Union.</description>
    <link>http://www.ibtimes.com/articles/20080912/boston-scientific-spent-400k-lobbying-govt-in-2q.htm</link> 
  <pubDate>Fri, 12 Sep 2008 16:22:36 EDT</pubDate>
  </item>


  <item>
  <title>Gerber Scientific to buy laser maker Virtek Vision</title>
  <description>Manufacturing systems maker Gerber Scientific Inc. on Friday agreed to buy industrial laser maker Virtek Vision International Inc. for $33.1 million. Virtek sells lasers used in marking, engraving, inspections and template making, and Gerber said the deal will give it approximately $50 million in additional annual revenue. Its bid was worth 35.1 million Canadian dollars, or 1.05 Canadian dollars per share.</description>
    <link>http://www.ibtimes.com/articles/20080905/gerber-scientific-to-buy-laser-maker-virtek-vision.htm</link> 
  <pubDate>Fri, 05 Sep 2008 08:43:07 EDT</pubDate>
  </item>


  <item>
  <title>Scientific Learning CFO Jane Freeman to resign</title>
  <description>Scientific Learning Corp. said Chief Financial Officer Jane A. Freeman has decided to resign in order to pursue other career opportunities. Controller Jon Corbett will serve as interim CFO until a permanent replacement is named, the educational software maker said late Thursday.</description>
    <link>http://www.ibtimes.com/articles/20080905/scientific-learning-cfo-jane-freeman-to-resign.htm</link> 
  <pubDate>Fri, 05 Sep 2008 08:00:01 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific reports drug-coated stent data</title>
  <description>Boston Scientific Corp. on Tuesday reported results from an aftermarket study of its drug-coated stent Taxus Liberte as the company attempts to gain approval to sell the device in the U.S.</description>
    <link>http://www.ibtimes.com/articles/20080902/boston-scientific-reports-drug-coated-stent-data.htm</link> 
  <pubDate>Tue, 02 Sep 2008 11:58:48 EDT</pubDate>
  </item>


  <item>
  <title>Court cuts Boston Scientific patent penalty</title>
  <description>Boston Scientific Corp. said Friday a U.S. District Court has reduced a patent dispute award owed to rival Medtronic Inc. from $250 million to $19 million.</description>
    <link>http://www.ibtimes.com/articles/20080829/court-cuts-boston-scientific-patent-penalty.htm</link> 
  <pubDate>Fri, 29 Aug 2008 14:48:18 EDT</pubDate>
  </item>


  <item>
  <title>Kewaunee Scientific declares quarterly dividend</title>
  <description>Kewaunee Scientific Corp. on Wednesday said its board declared a regular quarterly cash dividend of 8 cents per share. The laboratory furniture maker said the dividend will be payable on Sept. 22 to stockholders of record as of Sept. 8.</description>
    <link>http://www.ibtimes.com/articles/20080828/kewaunee-scientific-declares-quarterly-dividend.htm</link> 
  <pubDate>Thu, 28 Aug 2008 13:45:38 EDT</pubDate>
  </item>


  <item>
  <title>Gerber Scientific 1Q profit falls on weak sales</title>
  <description>Gerber Scientific Inc., which makes equipment to create signs and specialty graphics, said Thursday its fiscal 2009 first-quarter profit plunged 76 percent on continued weakness in several of the company's markets.</description>
    <link>http://www.ibtimes.com/articles/20080828/gerber-scientific-1q-profit-falls-on-weak-sales.htm</link> 
  <pubDate>Thu, 28 Aug 2008 10:17:20 EDT</pubDate>
  </item>


  <item>
  <title>Star Scientific shares soar on legal ruling</title>
  <description>Shares of tobacco company Star Scientific Inc. soared Monday afternoon after it said an appeals court ruled in its favor in a patent lawsuit against RJ Reynolds Tobacco Co., the nation's second-biggest tobacco company.</description>
    <link>http://www.ibtimes.com/articles/20080825/star-scientific-shares-soar-on-legal-ruling.htm</link> 
  <pubDate>Mon, 25 Aug 2008 13:21:08 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific recalls artery-opening stents</title>
  <description>Medical device maker Boston Scientific Corp. has recalled some of its artery-opening stents due to a defect that can cause part of the devices to break off during surgery.</description>
    <link>http://www.ibtimes.com/articles/20080814/boston-scientific-recalls-artery-opening-stents.htm</link> 
  <pubDate>Thu, 14 Aug 2008 18:19:20 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Boston Scientific, Nasdaq OMX</title>
  <description>Among the stock activity stories for Thursday, Aug. 14, from AP Financial News: WASHINGTON (AP)--Shares of medical device maker Boston Scientific Corp. fell Thursday as researchers raised new questions about the effectiveness of drug-coated stents, which are used to treat clogged arteries.</description>
    <link>http://www.ibtimes.com/articles/20080814/movers-roundup-boston-scientific-nasdaq-omx.htm</link> 
  <pubDate>Thu, 14 Aug 2008 14:37:34 EDT</pubDate>
  </item>


  <item>
  <title>Boston Scientific falls on new stent questions</title>
  <description>Shares of medical device maker Boston Scientific Corp. fell Thursday as researchers raised new questions about the effectiveness of drug-coated stents, which are used to treat clogged arteries.</description>
    <link>http://www.ibtimes.com/articles/20080814/boston-scientific-falls-on-new-stent-questions.htm</link> 
  <pubDate>Thu, 14 Aug 2008 19:55:05 EDT</pubDate>
  </item>


  <item>
  <title>Gerber Scientific reaffirms fiscal 2009 guidance</title>
  <description>Gerber Scientific Inc., which makes equipment to create signs and specialty graphics, on Wednesday reaffirmed its guidance for fiscal 2009 profit between 72 cents and 82 cents per share.</description>
    <link>http://www.ibtimes.com/articles/20080806/gerber-scientific-reaffirms-fiscal-2009-guidance.htm</link> 
  <pubDate>Wed, 06 Aug 2008 11:50:34 EDT</pubDate>
  </item>


</channel>
</rss>